Kestra Medical Technologies, Ltd. (KMTS) Operating Margin
- Operating margin · 12 months: Value -134.48%; Formula and calculation Operating income / revenue. Period ending 2026-07-31..
Operating margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -134.48% | Operating income / revenue. Period ending 2026-07-31. $-143.52M ÷ $106.73M × 100 ≈ -134.48% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -143.52M USD | Operating Income (Loss) |
| Revenue | 106.73M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 49.22M USD | Cost of Goods and Services Sold |
| Research and development | 22.28M USD | Research and Development Expense |
| Selling, general and administration | 178.75M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-31 | $-143.52M | $106.73M | $49.22M | $22.28M | $178.75M | -134.48% |
| 2026-04-30 | $-134.74M | $95.13M | $46.26M | $19.48M | $164.12M | -141.64% |
| 2026-01-31 | $-143.61M | $83.72M | $42.91M | $19.24M | $165.19M | -171.53% |
| 2025-10-31 | $-129.44M | $74.26M | $39.80M | $17.62M | $146.28M | -174.31% |
| 2025-07-31 | $-116.83M | $66.40M | $37.54M | $16.25M | $129.44M | -175.93% |
| 2025-04-30 | $-106.38M | $59.81M | $35.60M | $15.65M | $114.94M | -177.85% |
| 2025-01-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | $-85.06M | $27.81M | $27.45M | $15.49M | $69.94M | -305.83% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |